A Universal Imaging tool to Test the Efficacy of Anti-Corona Drugs

Summary of the technology

A Universal Imaging tool to Test the Efficacy of Anti-Corona Drugs
Project ID : 47-2020-10896

Yissum - Research Development Company of the Hebrew University

Details of the Technology Offer

We propose an imaging tool that will test the efficacy of a wide range of potential COVID-19 drugs. The imaging tool will enable high-resolution imaging of the infection process of a large number of single cells, by single virus sub-units (virions).

The types of drugs that can be tested will include those with small molecules and antibodies, targeted both against the virus proteins and against the infected cells at every stage of infection and development of the virus (i.e. before infection, at the time of infection, and afterwards). The efficacy test will be carried out quantitatively and comparatively, with and without the drug.

The efficacy testing will be based on an innovative technology developed at the Hebrew University, in the laboratory of Professor Eilon Sherman, who specializes in optical microscopy in super resolution. Prof. Sherman’s technology enables high resolution and controlled imaging of the interactions between cells, viruses and viral proteins.

To date, this technology has been demonstrated to work on numerous biological and clinical systems. The tool is expected to dramatically accelerate drug development and does not require involvement of human subjects or animal testing.

It has major advantages in terms of saving resources (money, equipment, etc.) as well as time required for the screening and development of antiviral drugs. Such advantages are critical for the rapid introduction of drugs into the market, as the cost of the development of any drug is valued at an average of 10 years and billions of dollars.

Project manager

Shani (Formal Employee) Bullock (Formal Employee)
VP, Business Development, Healthcare

Project researchers

Eilon Sherman
HUJI, Faculty of Science
The Racah Institute of Physics

Related Keywords

  • Infectious Diseases
  • Biological Sciences
  • Virus, Virology / Antibiotics / Bacteriology
  • In vitro Testing, Trials Technology
  • Imaging, Image Processing, Pattern Recognition
  • Covid-19
  • covid-19

About Yissum - Research Development Company of the Hebrew University

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. Founded in 1964 to protect and commercialize the Hebrew University’s intellectual property. Ranked among the top technology transfer companies, Yissum has registered over 8,900 patents covering 2,500 inventions; has licensed out 800 technologies and has spun-off 90 companies. Products that are based on Hebrew University technologies and were commercialized by Yissum generate today over $2 Billion in annual sales.

Yissum - Research Development Company of the Hebrew University

Never miss an update from Yissum - Research Development Company of the Hebrew University

Create your free account to connect with Yissum - Research Development Company of the Hebrew University and thousands of other innovative organizations and professionals worldwide

Yissum - Research Development Company of the Hebrew University

Send a request for information
to Yissum - Research Development Company of the Hebrew University

About Technology Offers

Technology Offers on Innoget are directly posted
and managed by its members as well as evaluation of requests for information. Innoget is the trusted open innovation and science network aimed at directly connect industry needs with professionals online.

Help

Need help requesting additional information or have questions regarding this Technology Offer?
Contact Innoget support